It is a chemicals private limited company based in Vadodara, Gujarat, India, established in 2015.
2015 | Vadodara, Gujarat, India | ActiveSolange Pharmaceuticals Private Limited, a active private limited company, was established on 19 February 2015 in Vadodara, Gujarat, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U24233GJ2015PTC082328. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ramesh Chandubhai Solanki (Director), Sheetal Uday Trivedi (Director), Dhaneshwar Chandulal Solanki (Director). Past directors included Ramesh Chandubhai Solanki. It holds ₹2.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-2, Dharik Appartment, Nr.Sadhana Nagar K Bag,, Vadodara, Gujarat, 390019.
U24233GJ2015PTC082328
082328
19 February 2015
₹2.00 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Solange Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Chandubhai Solanki | Director | 29 Mar 2024 | Current |
| Sheetal Uday Trivedi | Director | 19 Feb 2015 | Current |
| Dhaneshwar Chandulal Solanki | Director | 19 Feb 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Solange Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Solange Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 May 2016 | Others | ₹1.00 M | Open |
| 11 May 2016 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Solange Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Solange Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solange Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Solange Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Solange Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
Ramesh Chandubhai Solanki was appointed as a Director was appointed as a Director on 29 Mar 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 1.00 M with Charge ID 100042489 was registered on 24 May 2016. was documented.
A charge with Others amounted to Rs. 1.00 M with Charge ID 100042415 was registered on 11 May 2016. was recorded as a recent event.
The activity Sheetal Uday Trivedi was appointed as a Director was appointed as a Director on 19 Feb 2015 & has been associated with this company since 10 years 10 months . was completed.
The CIN of Solange Pharmaceuticals Private Limited is U24233GJ2015PTC082328.
Solange Pharmaceuticals Private Limited is headquartered at B-2, Dharik Appartment, Nr.Sadhana Nagar K Bag,, Vadodara, Gujarat, 390019.
Solange Pharmaceuticals Private Limited was incorporated on 19 February 2015.
The current directors of Solange Pharmaceuticals Private Limited are
The primary industry of Solange Pharmaceuticals Private Limited is Manufacturing.
Solange Pharmaceuticals Private Limited is unlisted.
The authorized capital of Solange Pharmaceuticals Private Limited is ₹2.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Solange Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX